Treatment With Avatrombopaq in Patients With Cirrhosis Undergoing Small Invasive Procedure: A Prospective Case Series
Latest Information Update: 05 Apr 2023
Price :
$35 *
At a glance
- Drugs Avatrombopag (Primary)
- Indications Liver cirrhosis; Thrombocytopenia
- Focus Adverse reactions
- Acronyms AIPAC
- 19 Apr 2021 New trial record